Update: 19.03.2024
Last week: 10 week 2024 (04.03.2024 - 10.03.2024)
Last full month: February 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 7 209 | -6.8% | 11.3% | 0.3 | 16 361 945 | -6.0% | 9.7% | 0.3 | -8.9% |
| MoM | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| YTD | 66 643 | 29.0% | 11.1% | 2.4 | 149 794 589 | 62.1% | 9.6% | 2.3 | 0.7% |
| MAT | 355 811 | 35.5% | 9.5% | 1.8 | 714 218 231 | 48.0% | 8.1% | 1.5 | 10.3% |
| BRAINMAX | |||||||||
| WoW | 909 | -18.3% | 100.0% | 0 | 3 361 275 | -19.4% | 100.0% | 0 | -18.3% |
| MoM | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| YTD | 9 626 | 79.6% | 100.0% | 0 | 34 759 270 | 92.8% | 100.0% | 0 | 79.6% |
| MAT | 50 917 | 227.5% | 100.0% | NA | 177 725 322 | 249.8% | 100.0% | NA | NA |
| GOLDLINE PLUS | |||||||||
| WoW | 16 511 | -8.7% | 43.6% | -2.5 | 51 867 195 | -11.0% | 35.4% | -3.7 | -3.5% |
| MoM | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| YTD | 159 605 | 6.0% | 43.7% | 2.4 | 514 484 517 | 13.5% | 36.1% | -1.2 | 0.2% |
| MAT | 878 139 | 23.1% | 45.4% | 2.5 | 2 753 077 678 | 32.0% | 39.4% | 1.9 | 16.4% |
| MIGRENIUM | |||||||||
| WoW | 12 232 | -0.1% | 0.6% | 0 | 3 664 257 | 2.3% | 0.7% | 0 | -0.9% |
| MoM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| YTD | 120 338 | 1.4% | 0.5% | -0.1 | 33 390 830 | 56.1% | 0.6% | 0.1 | 25.0% |
| MAT | 643 231 | 9.9% | 0.5% | 0 | 134 665 045 | 27.9% | 0.5% | 0 | 14.2% |
| MODELAX-N | |||||||||
| WoW | 37 989 | 6.9% | 28.8% | 3.5 | 15 868 517 | 7.8% | 18.5% | 2.6 | -5.9% |
| MoM | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| YTD | 302 626 | 63.6% | 22.4% | 5.3 | 122 544 051 | 106.8% | 13.7% | 3.9 | 24.6% |
| MAT | 1 285 669 | 135.3% | 19.7% | 9.4 | 446 081 041 | 145.5% | 11.2% | 5.3 | 23.3% |
| REDUXIN | |||||||||
| WoW | 12 727 | 3.8% | 33.6% | 2.4 | 68 211 762 | 7.2% | 46.5% | 3.9 | -3.5% |
| MoM | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| YTD | 121 841 | -5.5% | 33.4% | -2 | 657 498 322 | 23.0% | 46.1% | 2.1 | 0.2% |
| MAT | 630 705 | 4.0% | 32.6% | -3.9 | 2 996 070 408 | 17.7% | 42.8% | -2.8 | 16.4% |
| REDUXIN FORTE | |||||||||
| WoW | 3 453 | -1.4% | 9.1% | 0.2 | 15 113 216 | -2.8% | 10.3% | -0.1 | -3.5% |
| MoM | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| YTD | 32 110 | 11.6% | 8.8% | 0.9 | 142 682 010 | 34.7% | 10.0% | 1.3 | 0.2% |
| MAT | 169 352 | 34.4% | 8.7% | 1.2 | 690 305 672 | 44.8% | 9.9% | 1.3 | 16.4% |
| SALVISAR | |||||||||
| WoW | 10 800 | 13.8% | 1.5% | 0.3 | 4 294 442 | 15.8% | 1.3% | 0.3 | -6.0% |
| MoM | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
| YTD | 84 046 | -22.3% | 1.1% | -0.5 | 30 802 019 | -11.6% | 0.9% | -0.4 | 11.2% |
| MAT | 474 279 | -23.0% | 1.2% | -0.5 | 159 693 755 | -23.8% | 1.0% | -0.4 | 7.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 66 643 | 29.0% | 11.1% | 2.4 | 149 794 589 | 62.1% | 9.6% | 2.3 | 0.7% |
| BRAINMAX | 9 626 | 79.6% | 100.0% | 0 | 34 759 270 | 92.8% | 100.0% | 0 | 79.6% |
| GOLDLINE PLUS | 159 605 | 6.0% | 43.7% | 2.4 | 514 484 517 | 13.5% | 36.1% | -1.2 | 0.2% |
| MIGRENIUM | 120 338 | 1.4% | 0.5% | -0.1 | 33 390 830 | 56.1% | 0.6% | 0.1 | 25.0% |
| MODELAX-N | 302 626 | 63.6% | 22.4% | 5.3 | 122 544 051 | 106.8% | 13.7% | 3.9 | 24.6% |
| REDUXIN CAPS | 121 841 | -5.5% | 33.4% | -2 | 657 498 322 | 23.0% | 46.1% | 2.1 | 0.2% |
| REDUXIN FORTE | 32 110 | 11.6% | 8.8% | 0.9 | 142 682 010 | 34.7% | 10.0% | 1.3 | 0.2% |
| SALVISAR | 84 046 | -22.3% | 1.1% | -0.5 | 30 802 019 | -11.6% | 0.9% | -0.4 | 11.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 355 811 | 35.5% | 9.5% | 1.8 | 714 218 231 | 48.0% | 8.1% | 1.5 | 10.3% |
| BRAINMAX | 50 917 | 227.5% | 100.0% | NA | 177 725 322 | 249.8% | 100.0% | NA | NA |
| GOLDLINE PLUS | 878 139 | 23.1% | 45.4% | 2.5 | 2 753 077 678 | 32.0% | 39.4% | 1.9 | 16.4% |
| MIGRENIUM | 643 231 | 9.9% | 0.5% | 0 | 134 665 045 | 27.9% | 0.5% | 0 | 14.2% |
| MODELAX-N | 1 285 669 | 135.3% | 19.7% | 9.4 | 446 081 041 | 145.5% | 11.2% | 5.3 | 23.3% |
| REDUXIN CAPS | 630 705 | 4.0% | 32.6% | -3.9 | 2 996 070 408 | 17.7% | 42.8% | -2.8 | 16.4% |
| REDUXIN FORTE | 169 352 | 34.4% | 8.7% | 1.2 | 690 305 672 | 44.8% | 9.9% | 1.3 | 16.4% |
| SALVISAR | 474 279 | -23.0% | 1.2% | -0.5 | 159 693 755 | -23.8% | 1.0% | -0.4 | 7.2% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 7 209 | -6.8% | 11.3% | 0.3 | 16 361 945 | -6.0% | 9.7% | 0.3 | -8.9% |
| BRAINMAX | 909 | -18.3% | 100.0% | 0 | 3 361 275 | -19.4% | 100.0% | 0 | -18.3% |
| GOLDLINE PLUS | 16 511 | -8.7% | 43.6% | -2.5 | 51 867 195 | -11.0% | 35.4% | -3.7 | -3.5% |
| MIGRENIUM | 12 232 | -0.1% | 0.6% | 0 | 3 664 257 | 2.3% | 0.7% | 0 | -0.9% |
| MODELAX-N | 37 989 | 6.9% | 28.8% | 3.5 | 15 868 517 | 7.8% | 18.5% | 2.6 | -5.9% |
| REDUXIN CAPS | 12 727 | 3.8% | 33.6% | 2.4 | 68 211 762 | 7.2% | 46.5% | 3.9 | -3.5% |
| REDUXIN FORTE | 3 453 | -1.4% | 9.1% | 0.2 | 15 113 216 | -2.8% | 10.3% | -0.1 | -3.5% |
| SALVISAR | 10 800 | 13.8% | 1.5% | 0.3 | 4 294 442 | 15.8% | 1.3% | 0.3 | -6.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 29 171 | 8.3% | 11.0% | -0.1 | 65 772 614 | 9.3% | 9.5% | -0.1 | 9.6% |
| BRAINMAX | 3 949 | -7.8% | 100.0% | 0 | 14 394 547 | -5.2% | 100.0% | 0 | -7.8% |
| GOLDLINE PLUS | 68 306 | 1.9% | 43.8% | 0.3 | 217 517 575 | -1.1% | 35.9% | -0.2 | 1.2% |
| MIGRENIUM | 53 054 | 6.6% | 0.6% | 0.1 | 15 088 199 | 15.2% | 0.7% | 0.1 | -6.1% |
| MODELAX-N | 129 731 | 8.5% | 23.0% | 2.9 | 53 054 568 | 12.2% | 14.2% | 2.2 | -5.0% |
| REDUXIN CAPS | 51 307 | -2.3% | 32.9% | -1.2 | 277 156 731 | -2.7% | 45.7% | -1 | 1.2% |
| REDUXIN FORTE | 14 156 | 9.0% | 9.1% | 0.7 | 63 823 923 | 12.0% | 10.5% | 1.2 | 1.2% |
| SALVISAR | 35 330 | 4.5% | 1.1% | 0.1 | 13 170 717 | 12.2% | 1.0% | 0.1 | -3.3% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs